CN Patent

CN110511224A — 苯并二氮杂*衍生物的盐及其晶体形式、制备方法和用途

Assigned to Sichuan Kelun Pharmaceutical Research Co Ltd · Expires 2019-11-29 · 6y expired

What this patent protects

本发明涉及苯并二氮杂 衍生物(式(I)，3‑[(4S)‑8‑溴‑1‑甲基‑6‑(2‑吡啶基)‑4H‑咪唑并[1，2‑a][1，4]苯并二氮杂 ‑4‑基]丙酸甲酯)的草酸盐的晶体形式、包含其的药物组合物、制备方法和用途，特别是在制备用于镇静、催眠、抗焦虑、肌肉松弛或抗惊厥的药物中的用途。

USPTO Abstract

本发明涉及苯并二氮杂 衍生物(式(I)，3‑[(4S)‑8‑溴‑1‑甲基‑6‑(2‑吡啶基)‑4H‑咪唑并[1，2‑a][1，4]苯并二氮杂 ‑4‑基]丙酸甲酯)的草酸盐的晶体形式、包含其的药物组合物、制备方法和用途，特别是在制备用于镇静、催眠、抗焦虑、肌肉松弛或抗惊厥的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110511224A
Jurisdiction
CN
Classification
—
Expires
2019-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Pharmaceutical Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.